Magle Chemoswed Holding AB
STO:MAGLE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Magle Chemoswed Holding AB
Cash from Financing Activities
Magle Chemoswed Holding AB
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Magle Chemoswed Holding AB
STO:MAGLE
|
Cash from Financing Activities
kr55.5m
|
CAGR 3-Years
55%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
AddLife AB
STO:ALIF B
|
Cash from Financing Activities
-kr305m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Cash from Financing Activities
-kr455.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotage AB
STO:BIOT
|
Cash from Financing Activities
-kr157m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
|
G
|
Genovis AB
STO:GENO
|
Cash from Financing Activities
kr15.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
1%
|
|
|
MedCap AB (publ)
STO:MCAP
|
Cash from Financing Activities
kr52.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Magle Chemoswed Holding AB
Glance View
Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.
See Also
What is Magle Chemoswed Holding AB's Cash from Financing Activities?
Cash from Financing Activities
55.5m
SEK
Based on the financial report for Dec 31, 2025, Magle Chemoswed Holding AB's Cash from Financing Activities amounts to 55.5m SEK.
What is Magle Chemoswed Holding AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
19%
Over the last year, the Cash from Financing Activities growth was 224%. The average annual Cash from Financing Activities growth rates for Magle Chemoswed Holding AB have been 55% over the past three years , 19% over the past five years .
